Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer
Open Access
- 3 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (4), 671-678
- https://doi.org/10.1093/jrr/rrs131
Abstract
We analyzed the data for 53 patients with histologically proven primary squamous cell carcinoma of the head and neck treated with radiotherapy between February 2006 and August 2009. All patients underwent contrast-enhanced (CE)-CT and 18F-fluorodeoxyglucose (FDG)-PET before radiation therapy planning (RTP) to define the gross tumor volume (GTV). The PET-based GTV (PET-GTV) for RTP was defined using both CE-CT images and FDG-PET images. The CE-CT tumor volume corresponding to a FDG-PET image was regarded as the PET-GTV. The CE-CT-based GTV (CT-GTV) for RTP was defined using CE-CT images alone. Additionally, CT-GTV delineation and PET-GTV delineation were performed by four radiation oncologists independently in 19 cases. All four oncologists did both methods. Of these, PET-GTV delineation was successfully performed in all 19 cases, but CT-GTV delineation was not performed in 4 cases. In the other 15 cases, the mean CT-GTV was larger than the PET-GTV in 10 cases, and the standard deviation of the CT-GTV was larger than that of the PET-GTV in 10 cases. Sensitivity of PET-GTV for identifying the primary tumor was 96%, but that of CT-GTV was 81% (P < 0.01). In patients with oropharyngeal cancer and tongue cancer, the sensitivity of CT-GTV was 63% and 71%, respectively. When both the primary lesions and the lymph nodes were evaluated for RTP, PET-GTV differed from CT-GTV in 19 cases (36%). These results suggested that FDG-PET is effective for defining GTV in RTP for squamous cell carcinoma of the head and neck, and PET-GTV evaluated by both CE-CT and FDG-PET images is preferable to CT-GTV by CE-CT alone.Keywords
This publication has 28 references indexed in Scilit:
- Defining Radiotherapy Target Volumes Using 18F-Fluoro-Deoxy-Glucose Positron Emission Tomography/Computed Tomography: Still a Pandora's Box?International Journal of Radiation Oncology*Biology*Physics, 2010
- Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007Radiotherapy and Oncology, 2009
- Targeted Molecular Imaging in Oncology: Focus on Radiation TherapySeminars in Radiation Oncology, 2008
- Positron Emission Tomography/Computed Tomography for Target Delineation in Head and Neck CancersSeminars in Nuclear Medicine, 2008
- Positron Emission Tomography for Radiation Treatment PlanningStrahlentherapie und Onkologie, 2005
- Molecular (functional) imaging for radiotherapy applications: an RTOG symposiumInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomasInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Diagnosis and Staging of Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2000
- Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformalityInternational Journal of Radiation Oncology*Biology*Physics, 2000
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996